Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:29945229 | IVR | 30 mg/kg | 30 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg | 300 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations | |
PMID:31605871 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects superoxide dismutase (SOD) levels | Hepatic endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects liver function | Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects bile acid pathway | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects lipid metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects liver function | Hepatic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects superoxide dismutase (SOD) levels | Hepatic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects bile acid pathway | Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects liver function | Hepatic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects lipid metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects lipid metabolism | Metabolic endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.